Genomics Veteran to Lead Company Which Has a Commercial-Ready Novel Technology Platform that Can Realize the Largely Untapped Contribution of Epigenetics to Human Health CAMBRIDGE, United Kingdom -- Cambridge Epigenetix (CEGX), a life sciences tools and technology company which is revolutionizing genome sequencing, today announced the appointment of Peter J. Fromen as Chief Executive Officer [...]

Emeryville, CA (June 14, 2022) – SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Ozyme, a French company dedicated [...]

BOSTON, United States and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, today announced from the ESHG Conference in Vienna that it has achieved CE-IVD certification for the analytical functionality supported by its cloud-based SOPHiA DDM™ Platform, an accessory to diagnostic applications. With this certification, the SOPHiA DDM™ Platform is now IVD-ready [...]

BeginNGS™ to accelerate newborn screening by rapid whole genome sequencing to help diagnose and treat genetic diseases with available therapies SAN DIEGO -- Rady Children's Institute for Genomic Medicine (RCIGM®) today announced a novel program to advance and evaluate scalability of a diagnostic and precision medicine guidance tool called BeginNGS™ (pronounced "beginnings") to screen newborns for approximately 400 genetic diseases [...]

San Diego, California -- Dr. Kiana Aran, Associate Professor of Medical Diagnostics and Therapeutics at Keck Graduate Institute (KGI) and Chief Scientific Officer of Cardea Bio, recently received a Research Gift from Agilent Technologies' university relations program to support her research on developing a scalable detection platform to continuously monitor the quality and health of cell cultures using [...]

UPPSALA, Sweden -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that FinnGen in Finland will use Olink technology to provide detailed proteomics data to improve understanding of human health. FinnGen, is a large-scale academic/industrial research collaboration in Finland with the scope to collect and analyze genomic and health data from 500,000 Finnish biobank participants. It [...]

Norcross, GA, USA -- Micromeritics Instrument Corp., a global leader in material characterization technology, announced the release of the AutoChem III catalyst characterization system. Dynamic chemisorption and temperature-programmed reaction measurements by the AutoChem III provide performance metrics that are critical to developing the new catalyst materials that will drive technologies for carbon capture and utilization, [...]

Dublin, Ireland: ERS Genomics Limited (‘ERS’) is pleased to report that India Patent No. 397884 was granted on May 27, 2022. This patent covers methods and compositions for use of CRISPR/Cas9 and chimeric Cas9 in all cell types including eukaryotic cells. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to this foundational CRISPR/Cas9 [...]

DataApex is pleased to announce that a new control module for the Nexera LC-40 HPLC system has been released! It is a part of Clarity - Shimadzu Edition Chromatography Software that is dedicated to the European market. Customers can use a control module for the Nexera LC-40 HPLC system in combination with hundreds of instruments [...]

Chemical.AI-Scilligence Launched their Strategic Cooperation to Co-develop ELN-based Data Integration Chemical.AI, a high-tech company empowering chemistry with AI and ML, announced a strategic partnership with Scilligence, a web-based informatics solution provider for R&D. The two parties will co-develop high-efficiency data integration on Scilligence’s ELN with Chemical.AI’s leading AI-empowered route design systems (Retrosynthesis, forward synthesis, synthetic [...]